The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an ...

Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...

Some in the medical community say that antiviral treatments are underutilized and could help more people recover from ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Knowing when to seek treatment at urgent care vs. emergency department helps alleviate strain on healthcare system and ensure ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...